Erlotinib Tablets

Manufacturer: Zydus Lifesciences Limited
Effective date: 2024-11-28
Label type: HUMAN PRESCRIPTION DRUG LABEL
Version: 3
Source: full-release
Hydrated at: 2026-05-31 21:18:25

Label at a glance#

ProductErlotinib

Active ingredientERLOTINIB HYDROCHLORIDE

Label structure1 sections

Label contents#

Full prescribing information#

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Erlotinib Tablets, 25 mg

30 tablets

NDC 70771-1521-3

Rx only

Erlotinib Tablets, 100 mg

30 tablets

NDC 70771-1522-3

Rx only

Erlotinib Tablets, 150 mg

30 tablets

NDC 70771-1523-3

Rx only

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
603203	erlotinib 100 MG Oral Tablet	PSN	3
603206	erlotinib 150 MG Oral Tablet	PSN	3
603208	erlotinib 25 MG Oral Tablet	PSN	3
603203	erlotinib 100 MG Oral Tablet	SCD	3
603206	erlotinib 150 MG Oral Tablet	SCD	3
603208	erlotinib 25 MG Oral Tablet	SCD	3
603208	erlotinib (as erlotinib hydrochloride) 25 MG Oral Tablet	SY	3
603203	erlotinib 100 MG (equivalent to erlotinib HCl 109.3 MG) Oral Tablet	SY	3
603206	erlotinib 150 MG (equivalent to erlotinib HCl 163.9 MG) Oral Tablet	SY	3

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
ERLOTINIB Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
bd23d1a5-e4ff-4f92-da3b-5034c014ad1a	Product name	8	20250331

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
70771-1521-2	Erlotinib	10 in 1 BLISTER PACK	TABLET, FILM COATED	10	3
70771-1521-3	Erlotinib	30 in 1 BOTTLE	TABLET, FILM COATED	30	3
70771-1521-7	Erlotinib	3 in 1 CARTON	TABLET, FILM COATED	3	3
70771-1521-9	Erlotinib	90 in 1 BOTTLE	TABLET, FILM COATED	90	3
70771-1522-2	Erlotinib	10 in 1 BLISTER PACK	TABLET, FILM COATED	10	3
70771-1522-3	Erlotinib	30 in 1 BOTTLE	TABLET, FILM COATED	30	3
70771-1522-7	Erlotinib	3 in 1 CARTON	TABLET, FILM COATED	3	3
70771-1522-9	Erlotinib	90 in 1 BOTTLE	TABLET, FILM COATED	90	3
70771-1523-2	Erlotinib	10 in 1 BLISTER PACK	TABLET, FILM COATED	10	3
70771-1523-3	Erlotinib	30 in 1 BOTTLE	TABLET, FILM COATED	30	3
70771-1523-7	Erlotinib	3 in 1 CARTON	TABLET, FILM COATED	3	3
70771-1523-9	Erlotinib	90 in 1 BOTTLE	TABLET, FILM COATED	90	3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
70771-1521	ERLOTINIB TABLET, FILM COATED [ZYDUS LIFESCIENCES LIMITED]	3	Current NDC, Legacy NDC, 4 package rows	20241201_daaa1329-3a3f-439c-b13d-b301daa234d4.zip
70771-1522	ERLOTINIB TABLET, FILM COATED [ZYDUS LIFESCIENCES LIMITED]	3	Current NDC, Legacy NDC, 4 package rows	20241201_daaa1329-3a3f-439c-b13d-b301daa234d4.zip
70771-1523	ERLOTINIB TABLET, FILM COATED [ZYDUS LIFESCIENCES LIMITED]	3	Current NDC, Legacy NDC, 4 package rows	20241201_daaa1329-3a3f-439c-b13d-b301daa234d4.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

Erlotinib
ERLOTINIB HYDROCHLORIDE
CROSPOVIDONE (120 .MU.M)
HYPROMELLOSE 2910 (6 MPA.S)
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
MICROCRYSTALLINE CELLULOSE 101
MICROCRYSTALLINE CELLULOSE 102
POLYETHYLENE GLYCOL 4000
SILICON DIOXIDE
SODIUM LAURYL SULFATE
TALC
TITANIUM DIOXIDE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
70771-1521	70771-1521-3, 70771-1521-9, 70771-1521-2, 70771-1521-7
70771-1522	70771-1522-3, 70771-1522-9, 70771-1522-2, 70771-1522-7
70771-1523	70771-1523-3, 70771-1523-9, 70771-1523-2, 70771-1523-7

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 36 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
ERLOTINIB HYDROCHLORIDE	DA87705X9K	ACTIM
CROSPOVIDONE (120 .MU.M)	68401960MK	IACT
HYPROMELLOSE 2910 (6 MPA.S)	0WZ8WG20P6	IACT
LACTOSE MONOHYDRATE	EWQ57Q8I5X	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
MICROCRYSTALLINE CELLULOSE 101	7T9FYH5QMK	IACT
MICROCRYSTALLINE CELLULOSE 102	PNR0YF693Y	IACT
POLYETHYLENE GLYCOL 4000	4R4HFI6D95	IACT
SILICON DIOXIDE	ETJ7Z6XBU4	IACT
SODIUM LAURYL SULFATE	368GB5141J	IACT
TALC	7SEV7J4R1U	IACT
TITANIUM DIOXIDE	15FIX9V2JP	IACT
ERLOTINIB HYDROCHLORIDE	DA87705X9K	ACTIM
CROSPOVIDONE (120 .MU.M)	68401960MK	IACT
HYPROMELLOSE 2910 (6 MPA.S)	0WZ8WG20P6	IACT
LACTOSE MONOHYDRATE	EWQ57Q8I5X	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
MICROCRYSTALLINE CELLULOSE 101	7T9FYH5QMK	IACT
MICROCRYSTALLINE CELLULOSE 102	PNR0YF693Y	IACT
POLYETHYLENE GLYCOL 4000	4R4HFI6D95	IACT
SILICON DIOXIDE	ETJ7Z6XBU4	IACT
SODIUM LAURYL SULFATE	368GB5141J	IACT
TALC	7SEV7J4R1U	IACT
TITANIUM DIOXIDE	15FIX9V2JP	IACT
ERLOTINIB HYDROCHLORIDE	DA87705X9K	ACTIM
CROSPOVIDONE (120 .MU.M)	68401960MK	IACT
HYPROMELLOSE 2910 (6 MPA.S)	0WZ8WG20P6	IACT
LACTOSE MONOHYDRATE	EWQ57Q8I5X	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
MICROCRYSTALLINE CELLULOSE 101	7T9FYH5QMK	IACT
MICROCRYSTALLINE CELLULOSE 102	PNR0YF693Y	IACT
POLYETHYLENE GLYCOL 4000	4R4HFI6D95	IACT
SILICON DIOXIDE	ETJ7Z6XBU4	IACT
SODIUM LAURYL SULFATE	368GB5141J	IACT
TALC	7SEV7J4R1U	IACT
TITANIUM DIOXIDE	15FIX9V2JP	IACT

Source Document#

Source XML · Source PDF

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A213065-001	ERLOTINIB HYDROCHLORIDE	ERLOTINIB HYDROCHLORIDE	EQ 25MG BASE	TABLET / ORAL	AB		2020-04-16
A213065-002	ERLOTINIB HYDROCHLORIDE	ERLOTINIB HYDROCHLORIDE	EQ 100MG BASE	TABLET / ORAL	AB		2020-04-16
A213065-003	ERLOTINIB HYDROCHLORIDE	ERLOTINIB HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	AB	RS	2020-04-16

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A213065-001	AB
A213065-002	AB
A213065-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 117 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A213065-001	ERLOTINIB HYDROCHLORIDE	EQ 25MG BASE	TABLET / ORAL	AB		2020-04-16	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A213065-002	ERLOTINIB HYDROCHLORIDE	EQ 100MG BASE	TABLET / ORAL	AB		2020-04-16	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A213065-003	ERLOTINIB HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	AB	RS	2020-04-16	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A213065-001	ERLOTINIB HYDROCHLORIDE	EQ 25MG BASE	TABLET / ORAL	AB		2020-04-16	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A213065-002	ERLOTINIB HYDROCHLORIDE	EQ 100MG BASE	TABLET / ORAL	AB		2020-04-16	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A213065-003	ERLOTINIB HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	AB	RS	2020-04-16	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A213065-001	ERLOTINIB HYDROCHLORIDE	EQ 25MG BASE	TABLET / ORAL	AB		2020-04-16	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A213065-002	ERLOTINIB HYDROCHLORIDE	EQ 100MG BASE	TABLET / ORAL	AB		2020-04-16	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A213065-003	ERLOTINIB HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	AB	RS	2020-04-16	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A213065-001	ERLOTINIB HYDROCHLORIDE	EQ 25MG BASE	TABLET / ORAL	AB		2020-04-16	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A213065-002	ERLOTINIB HYDROCHLORIDE	EQ 100MG BASE	TABLET / ORAL	AB		2020-04-16	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A213065-003	ERLOTINIB HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	AB	RS	2020-04-16	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A213065-001	ERLOTINIB HYDROCHLORIDE	EQ 25MG BASE	TABLET / ORAL	AB		2020-04-16	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A213065-002	ERLOTINIB HYDROCHLORIDE	EQ 100MG BASE	TABLET / ORAL	AB		2020-04-16	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A213065-003	ERLOTINIB HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	AB	RS	2020-04-16	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A213065-001	ERLOTINIB HYDROCHLORIDE	EQ 25MG BASE	TABLET / ORAL	AB		2020-04-16	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A213065-002	ERLOTINIB HYDROCHLORIDE	EQ 100MG BASE	TABLET / ORAL	AB		2020-04-16	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A213065-003	ERLOTINIB HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	AB	RS	2020-04-16	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A213065-001	ERLOTINIB HYDROCHLORIDE	EQ 25MG BASE	TABLET / ORAL	AB		2020-04-16	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A213065-002	ERLOTINIB HYDROCHLORIDE	EQ 100MG BASE	TABLET / ORAL	AB		2020-04-16	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A213065-003	ERLOTINIB HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	AB	RS	2020-04-16	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A213065-001	ERLOTINIB HYDROCHLORIDE	EQ 25MG BASE	TABLET / ORAL	AB		2020-04-16	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A213065-002	ERLOTINIB HYDROCHLORIDE	EQ 100MG BASE	TABLET / ORAL	AB		2020-04-16	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A213065-003	ERLOTINIB HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	AB	RS	2020-04-16	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A213065-001	ERLOTINIB HYDROCHLORIDE	EQ 25MG BASE	TABLET / ORAL	AB		2020-04-16	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A213065-002	ERLOTINIB HYDROCHLORIDE	EQ 100MG BASE	TABLET / ORAL	AB		2020-04-16	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A213065-003	ERLOTINIB HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	AB	RS	2020-04-16	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A213065-001	ERLOTINIB HYDROCHLORIDE	EQ 25MG BASE	TABLET / ORAL	AB		2020-04-16	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A213065-002	ERLOTINIB HYDROCHLORIDE	EQ 100MG BASE	TABLET / ORAL	AB		2020-04-16	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A213065-003	ERLOTINIB HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	AB	RS	2020-04-16	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A213065-001	ERLOTINIB HYDROCHLORIDE	EQ 25MG BASE	TABLET / ORAL	AB		2020-04-16	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A213065-002	ERLOTINIB HYDROCHLORIDE	EQ 100MG BASE	TABLET / ORAL	AB		2020-04-16	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A213065-003	ERLOTINIB HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	AB	RS	2020-04-16	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A213065-001	ERLOTINIB HYDROCHLORIDE	EQ 25MG BASE	TABLET / ORAL	AB		2020-04-16	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A213065-002	ERLOTINIB HYDROCHLORIDE	EQ 100MG BASE	TABLET / ORAL	AB		2020-04-16	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A213065-003	ERLOTINIB HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	AB	RS	2020-04-16	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A213065-001	ERLOTINIB HYDROCHLORIDE	EQ 25MG BASE	TABLET / ORAL	AB		2020-04-16	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A213065-002	ERLOTINIB HYDROCHLORIDE	EQ 100MG BASE	TABLET / ORAL	AB		2020-04-16	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A213065-003	ERLOTINIB HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	AB	RS	2020-04-16	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A213065-001	ERLOTINIB HYDROCHLORIDE	EQ 25MG BASE	TABLET / ORAL	AB		2020-04-16	`301d65b070ca…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 117 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	A213065-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A213065-002	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A213065-003	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A213065-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A213065-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A213065-003	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A213065-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A213065-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A213065-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A213065-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A213065-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A213065-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A213065-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A213065-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A213065-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A213065-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A213065-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A213065-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A213065-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A213065-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A213065-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A213065-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A213065-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A213065-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A213065-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A213065-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A213065-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A213065-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A213065-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A213065-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A213065-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A213065-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A213065-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A213065-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A213065-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A213065-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A213065-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A213065-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A213065-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A213065-001	AB	1	`301d65b070ca…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Erlotinib	ERLOTINIB	Zydus Lifesciences Limited	daaa1329-3a3f-439c-b13d-b301daa234d4	2024-11-28		Exact identifier ndc (package): 70771-1523-2 ndc (package): 70771-1521-2 ndc (package): 70771-1523-7 ndc (package): 70771-1522-2 ndc (package): 70771-1521-3 ndc (package): 70771-1522-9 ndc (package): 70771-1522-3 ndc (package): 70771-1523-3 ndc (package): 70771-1521-9 ndc (package): 70771-1522-7 ndc (package): 70771-1523-9 ndc (package): 70771-1521-7 ndc (product): 70771-1523 ndc (product): 70771-1522 ndc (product): 70771-1521 ndc11 (package): 70771152309 ndc11 (package): 70771152109 ndc11 (package): 70771152103 ndc11 (package): 70771152209 ndc11 (package): 70771152303 ndc11 (package): 70771152207 ndc11 (package): 70771152307 ndc11 (package): 70771152302 ndc11 (package): 70771152102 ndc11 (package): 70771152107 ndc11 (package): 70771152203 ndc11 (package): 70771152202 spl id: 9d253beb-cd1f-45df-9b23-c521269d419f spl set id: daaa1329-3a3f-439c-b13d-b301daa234d4

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.